AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic stem cell transplantation (HSCT) is frequently used to obtain a tumor-free graft. The majority of published experience is with peripheral blood stem cell (PBSC) products; only scant information has been published on bone marrow (BM) grafts. We reviewed our experience using CD34+ selection of BM grafts in children undergoing autologous BM transplantation. After obtaining institutional approval, we performed a retrospective review of the medical records of patients who underwent autologous stem cell collection at St. Jude. From January 1, 1999, to December 31, 2003, 373 patients underwent autologous HSCT; 131 received marrow grafts, 237 received P...
AbstractObjectiveHematopoietic stem cell transplantation has been successfully used to treat the ped...
AbstractIntroductionThe use of peripheral hematopoietic progenitor cells (HPCs) is the cell choice i...
Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) are considered the standard...
AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic ste...
AbstractBackground aimsImmunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using pa...
Background: Clonogenic tumor cells in the hematopoietic progenitor cell harvest may contribute to re...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
AbstractThirty-five pediatric patients, 1-16 years of age (median 6.3 years), with neoplastic solid ...
AbstractWe investigated whether a novel chemotherapy-alone conditioning regimen would permit durable...
AbstractAutosomal recessive osteopetrosis (OP) is a rare, lethal disorder in which osteoclasts are a...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
AbstractUnmanipulated haploidentical blood and marrow transplantation has been developed as an alter...
Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
AbstractCord blood (CB) and autologous mobilized peripheral blood stem/progenitor cells (PBSC) are n...
AbstractObjectiveHematopoietic stem cell transplantation has been successfully used to treat the ped...
AbstractIntroductionThe use of peripheral hematopoietic progenitor cells (HPCs) is the cell choice i...
Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) are considered the standard...
AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic ste...
AbstractBackground aimsImmunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using pa...
Background: Clonogenic tumor cells in the hematopoietic progenitor cell harvest may contribute to re...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
AbstractThirty-five pediatric patients, 1-16 years of age (median 6.3 years), with neoplastic solid ...
AbstractWe investigated whether a novel chemotherapy-alone conditioning regimen would permit durable...
AbstractAutosomal recessive osteopetrosis (OP) is a rare, lethal disorder in which osteoclasts are a...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
AbstractUnmanipulated haploidentical blood and marrow transplantation has been developed as an alter...
Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
AbstractCord blood (CB) and autologous mobilized peripheral blood stem/progenitor cells (PBSC) are n...
AbstractObjectiveHematopoietic stem cell transplantation has been successfully used to treat the ped...
AbstractIntroductionThe use of peripheral hematopoietic progenitor cells (HPCs) is the cell choice i...
Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) are considered the standard...